Transcranial Magnetic Stimulation as a Treatment of Depression and Other Psychiatric/Neurologic Disorders
Customize your policy alerts
Sign up for lucet Policy 00121 alerts
Get alerted when Policy 00121 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage of transcranial magnetic stimulation using an FDA-cleared device for major depressive disorder and identifies TMS uses that are investigational. It applies to products administered or underwritten by Blue Cross and Blue Shield of Louisiana and HMO Louisiana, Inc., subject to the member’s contract.
The eligible-for-coverage statement for TMS for treatment-resistant depression was revised to require use of an FDA-cleared device and modality.
The policy history records multiple format revisions, including addition of FDA and other governmental regulatory approval information, with some entries explicitly stating that there was no substance change to the policy.
Coverage changed from investigational to eligible with criteria for transcranial magnetic stimulation of the brain for treatment-resistant depression.
The policy history identifies continued transcranial magnetic stimulation as maintenance therapy and treatment of other psychiatric or neurologic disorders as investigational.
Information on TMS modalities, including theta burst stimulation, was added to the Policy Guidelines.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.